Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy
Rajesh Thaman, MRCP, MD* ,
Juan R. Gimeno, MD* ,
Sebastian Reith, MD* ,
Maria T. Tome Esteban, MD* ,
Giuseppe Limongelli, MD* ,
Ross T. Murphy, MRCPI, MD* ,
Bryan Mist, PhD* ,
William J. McKenna, MD, FRCP, FESC, FACC* and
Perry M. Elliott, MD, MRCP, FACC ,*
* Department of Cardiological Sciences, St. George's Hospital Medical School, London, United Kingdom
The Heart Hospital, University College London, London, United Kingdom

View larger version (20K):
[in a new window]
|
Figure 1 Age distribution of the 106 patients studied and sudden death (darker shading in bars represents sudden deaths).
|
|

View larger version (20K):
[in a new window]
|
Figure 2 Kaplan-Meier survival estimates free from sudden cardiac death, heart failure/transplantation, and all-cause mortality in the study population.
|
|

View larger version (14K):
[in a new window]
|
Figure 3 Kaplan-Meier survival estimates free from sudden cardiac death for patients with one or more risk factors. LVH = left ventricular hypertrophy.
|
|
|